Replies to post #30047 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

I've been saying for the past several weeks that I anticipate at least $20M in fiscal 2018 revs from their MNK/SeroquelXR deal and $5M revs from their PAR/FocalinXR deal...so how is the Maxim analyst smoking crack by projecting another +$9M if one of both already partnered MNK ANDA's receives FDA approval by/b4 years end?